Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States

Published:2018-04-25 Issue:5 Volume:38 Page:520-530
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Zueger Patrick M.¹,Kumar Varun M.²,Harrington Rachel L.¹,Rigoni Gianna C.¹,Atwood Alicia³,DiDomenico Robert J.⁴⁵,Touchette Daniel R.¹⁵^ORCID

Affiliation:

1. Department of Pharmacy Systems, Outcomes and Policy; College of Pharmacy; University of Illinois at Chicago; Chicago Illinois

2. Institute for Clinical and Economic Review; Boston Massachusetts

3. Economics Department; University of Illinois at Chicago; Chicago Illinois

4. Department of Pharmacy Practice; College of Pharmacy; University of Illinois at Chicago; Chicago Illinois

5. Center for Pharmacoepidemiology and Pharmacoeconomic Research; College of Pharmacy; University of Illinois at Chicago; Chicago Illinois

Funder

National Cancer Institute

Publisher

Wiley

Subject

Pharmacology (medical)

Reference49 articles.

1. Heart disease and stroke statistics-2013 update: a report from the American Heart Association;Go;Circulation,2013

2. Epidemiology of heart failure;Roger;Circ Res,2013

3. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association;Heidenreich;Circulation,2011

4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

5. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group;The CONSENSUS Trial Study Group;N Engl J Med,1987

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial;Circulation;2023-10-03

2. Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review;Value in Health;2023-10

3. Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis;Frontiers in Pharmacology;2023-03-02

4. Cost effectiveness analyses of pharmacological treatments in heart failure;Frontiers in Pharmacology;2022-09-05

5. Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review;The European Journal of Health Economics;2022-07-05